Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-06-29 @ 6:48 PM
Study NCT ID:
NCT07477132
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-03-17
First Post:
2026-03-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Dose-response Study to Determine the Right Dosage of Sugammadex as a Reversal Agent of Rocuronium in Infants Between 1 and 24 Months Old
Sponsor:
University Hospital, Caen